Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Qmax/eGFR Ratio in Assessing Symptom Severity and QoL in Men Over 40 With LUTS

NCT07055425 is registered in ClinicalTrials.gov with Marmara University as lead sponsor.

NCT NCT07055425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07055425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Qmax/eGFR Ratio in Assessing Symptom Severity and QoL in Men Over 40 With LUTS
Lead sponsor
Marmara University
Phase
Observational
Overall status
Not yet recruiting
Start date
September 1, 2025
Completion date
May 1, 2026
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostate obstruction (bpo), lower urinary tract symptom, male urological health, renal function, voiding dysfunction